A study revealed that RIDD regulates expression of the MHC-I heavy chain mRNAs in DCs and that pharmacological IRE1 RNase inhibition attenuates tumor growth in 4T1 and CT26 models, by a mechanism proposed to be dependent on DC cross-presentation (55). The gene discussed is ERN1; the disease is neoplasm.